Skip to main content

Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF.

Hansson O, Rutz S, Zetterberg H, Bauer E, Hähl T, Manuilova E, Mert MC, Wahl S, Blennow K, Stomrud E

Publication: Alzheimers Dement (Amst) (2020) • Vol 12 • Page e12137PMID: 33354617View on PubMed

Purpose

This paper investigated the effects of preanalytical factors including tube types, fill volume, mixing methods, storage duration, centrifugation, and transport conditions on the measurement of Alzheimer’s biomarkers in cerebrospinal fluid (CSF).

Conclusion

Recovery of amyloid β (Aβ)1-42 from CSF was approximately 100%, with little variability between replicates when 2.5 or 1.66 mL CSF was placed in Low-Bind Sarstedt False Bottom (FBT) tubes but was higher or lower than expected or more variable when other tubes or volumes were used. Generally, levels of Aβ1-42 were comparable between aliquots collected by gravity drip and lumbar fluid manometer (LFM) and over the course of lumbar puncture but the first collection by LFM was more variable. While effects of mixing, storage, and transport were observed, they could be attenuated by tube filling, storage/transport at 2-8°C, and/or transporting tubes upright. Levels of Aβ1-42 were largely unaffected by contamination with blood or centrifugation. Overall, similar results were observed for Aβ1-40 as Aβ1-42 but the magnitude of the changes were smaller and occasionally in the opposite direction. Phospho (P)-tau and Total (T)-tau levels were less affected by preanalytical factors. The authors conclude that CSF should be collected as >2.5 mL aliquots in Low-Bind FBT tubes and transported/stored at 2-8°C.

Studies (2)

Purpose

This study investigated the effect of tube type and fill volume on the measurement of biomarkers in CSF. Commercially obtained CSF was thawed for 30 min and 2.5, 1.66, and 0.75 mL were aliquoted into Sarstedt Low-Bind FBT tubes; 1.23 and 0.65 mL in Sarstedt 2.0 mL tubes; 2.0, 1.61, and 1.0 mL in Nunc tubes; 1.0, 0.84, and 0.5 mL in Eppendorf tubes (LoBind and Snap-Cap); and 0.63, 0.5, and 0.35 mL in Sarstedt 0.5 mL and Nalgene 0.5 mL tubes. Levels of Aβ1-42, Aβ1-40, P-tau, and T-tau were measured using Elecsys immunoassays on a Cobas e601 Analyzer.

Summary of Findings

Recovery of Aβ1-42 from CSF was approximately 100% with little variability between replicates when CSF was in Low-Bind Sarstedt FBT tubes filled with 2.5 or 1.66 mL but higher than expected when Starstedt 2.0 mL tubes were filled with 1.23 mL and when Nunc tubes were filled with 1.61 mL and lower than expected when Low-Bind Sarstedt FBT tubes were filled with 0.75 mL, Ependorf SnapCap tubes were filled with 0.5 or 1.0 mL, Sarstedt 2.0 tubes were filled with 0.65 mL, Nunc tubes were filled with 2.0 mL, or when Sarstedt or Nalgene 0.5 mL tubes were used, regardless of volume. Recovery of Aβ1-42 from CSF was 95-105% for all replicates, regardless of volume, when Eppendorf LoBind tubes were used but variability was higher than that in the Sarstedt Low-Bind FBT tubes. Importantly, recovery was lower in non-Low-Bind Sarstedt FBT tubes than in Sarstedt Low-Bind tubes, though the magnitude of the effect was small. There was no effect of sterilization of Sarstedt FBT tubes on recovery of Aβ1-42 from CSF.

  • Biospecimens

    FluidCerebrospinal Fluid
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
  • Platforms

    ProteinClinical chemistry/auto analyzer
    PeptideClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    Eppendorf LoBind tube
    Eppendorf Snap-Cap tube
    Low-Bind Sarstedt FBT tube
    Nalgene 0.5 mL tube
    Nunc tube
    Starstedt 0.5 mL tube
    Starstedt 2.0 mL tube
    Starstedt FBT tube
    Biospecimen Aliquots and ComponentsAliquot size/volume
    0.35 mL
    0.5 mL
    0.63 mL
    0.65 mL
    0.84 mL
    1.0 mL
    1.23 mL
    1.6 mL
    2.0 mL
    2.5 mL